126 related articles for article (PubMed ID: 8870923)
1. Phenotypic variability in monozygotic twins with neurofibromatosis 2.
Baser ME; Ragge NK; Riccardi VM; Janus T; Gantz B; Pulst SM
Am J Med Genet; 1996 Sep; 64(4):563-7. PubMed ID: 8870923
[TBL] [Abstract][Full Text] [Related]
2. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic variability associated with 14 splice-site mutations in the NF2 gene.
Kluwe L; MacCollin M; Tatagiba M; Thomas S; Hazim W; Haase W; Mautner VF
Am J Med Genet; 1998 May; 77(3):228-33. PubMed ID: 9605590
[TBL] [Abstract][Full Text] [Related]
4. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
5. A point mutation associated with a severe phenotype of neurofibromatosis 2.
MacCollin M; Braverman N; Viskochil D; Ruttledge M; Davis K; Ojemann R; Gusella J; Parry DM
Ann Neurol; 1996 Sep; 40(3):440-5. PubMed ID: 8797533
[TBL] [Abstract][Full Text] [Related]
6. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.
Parry DM; Eldridge R; Kaiser-Kupfer MI; Bouzas EA; Pikus A; Patronas N
Am J Med Genet; 1994 Oct; 52(4):450-61. PubMed ID: 7747758
[TBL] [Abstract][Full Text] [Related]
8. Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).
Zhao Y; Kumar RA; Baser ME; Evans DG; Wallace A; Kluwe L; Mautner VF; Parry DM; Rouleau GA; Joe H; Friedman JM
Genet Epidemiol; 2002 Oct; 23(3):245-59. PubMed ID: 12384977
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
[TBL] [Abstract][Full Text] [Related]
10. Further genotype--phenotype correlations in neurofibromatosis 2.
Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
[TBL] [Abstract][Full Text] [Related]
11. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
Welling DB
Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
[TBL] [Abstract][Full Text] [Related]
13. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
14. Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder.
van der Schot AC; Vonk R; Brans RG; van Haren NE; Koolschijn PC; Nuboer V; Schnack HG; van Baal GC; Boomsma DI; Nolen WA; Hulshoff Pol HE; Kahn RS
Arch Gen Psychiatry; 2009 Feb; 66(2):142-51. PubMed ID: 19188536
[TBL] [Abstract][Full Text] [Related]
15. Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma.
Zirn B; Arning L; Bartels I; Shoukier M; Hoffjan S; Neubauer B; Hahn A
Clin Genet; 2012 Jan; 81(1):82-7. PubMed ID: 21175598
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis type 2: a new mechanism of tumor suppression.
Lutchman M; Rouleau GA
Trends Neurosci; 1996 Sep; 19(9):373-7. PubMed ID: 8873351
[TBL] [Abstract][Full Text] [Related]
17. Two pairs of proven monozygotic twins discordant for familial amyloid neuropathy (FAP) TTR Met 30.
Munar-Qués M; Pedrosa JL; Coelho T; Gusmão L; Seruca R; Amorim A; Sequeiros J
J Med Genet; 1999 Aug; 36(8):629-32. PubMed ID: 10465115
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type 2 discordance in monozygous twins.
Amico S; Smith P; Tobi S; Perry M; Wallace A; Evans DG
Fam Cancer; 2020 Jan; 19(1):37-40. PubMed ID: 31965447
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis type 2: genetic and clinical features.
Evans DG
Ear Nose Throat J; 1999 Feb; 78(2):97-100. PubMed ID: 10089694
[TBL] [Abstract][Full Text] [Related]
20. [Type 2 neurofibromatosis without acoustic neuroma].
Mautner VF; Lindenau M; Köppen J; Hazim W; Kluwe L
Zentralbl Neurochir; 1995; 56(2):83-7. PubMed ID: 7639047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
